Lu Henri, Vollenweider Peter, Kissling Sébastien, Marques-Vidal Pedro
Department of Cardiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Department of Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Front Med (Lausanne). 2020 Sep 11;7:512. doi: 10.3389/fmed.2020.00512. eCollection 2020.
Hyponatremia (serum sodium concentration <135 mEq/L) is the most common electrolyte abnormality among hospitalized patients. Our aim was to study the epidemiology of hyponatremia in hospitalized patients, as well as the short-term mortality rates, the length of stay (LOS), and associated hospital costs. This retrospective cohort study included 6,539 hospitalizations in the internal medicine ward of a Swiss tertiary-care teaching hospital between January 1, 2012, and December 31, 2018 (42.7% women, mean age 69 years). Using serum sodium concentration, we identified hospitalizations with hyponatremia and calculated the prevalence of overall hyponatremia, admission hyponatremia (AH), hospital-acquired hyponatremia (HAH), and persistent hyponatremia (PH) at discharge. We also studied the impact of hyponatremia on 30-day readmissions, in-hospital and 30-day mortality, and hospital LOS and costs, using multivariable logistic regression and Cox proportional hazards models, with normal natremia as reference. Prevalence of overall hyponatremia was 32.5% [95% confidence interval (CI), 31.3-33.6%], while prevalence of PH among hospitalizations with AH and HAH was 33.7% (31.7-35.8%). After multivariable adjustment, hyponatremia was associated with increased hospital costs (CHF 19,025 ± 485 vs. 14,962 ± 341, < 0.001) and LOS (13.4 ± 0.2 vs. 10.7 ± 0.2 days, < 0.001). Increased severity of hyponatremia was associated with higher hospital costs and LOS ( for trend <0.001). There was a trend toward more frequent 30-day readmissions associated with hyponatremia [adjusted odds ratio (OR), 1.15 (1.01-1.31), = 0.032], mainly with PH: adjusted OR = 1.41 (1.17-1.71), < 0.001. No association was found between severity of hyponatremia and readmissions. Hyponatremia was associated with an increase of in-hospital [adjusted OR = 1.94 (1.49-2.53), < 0.001] and 30-day mortality: adjusted OR = 1.80 (1.44-2.24), < 0.001. Increased severity of hyponatremia was associated with higher in-hospital and 30-day mortality ( for trend < 0.001). Hyponatremia is highly prevalent among hospitalized patients and associated with an increase of LOS, early hospital readmission, in-hospital and 30-day mortality, and hospital costs. PH was associated with a substantial increase of the risk of early hospital readmission and 30-day mortality.
低钠血症(血清钠浓度<135 mEq/L)是住院患者中最常见的电解质异常情况。我们的目的是研究住院患者低钠血症的流行病学情况,以及短期死亡率、住院时间(LOS)和相关的住院费用。这项回顾性队列研究纳入了2012年1月1日至2018年12月31日期间瑞士一家三级医疗教学医院内科病房的6539例住院病例(女性占42.7%,平均年龄69岁)。我们根据血清钠浓度确定了低钠血症的住院病例,并计算了总体低钠血症、入院时低钠血症(AH)、医院获得性低钠血症(HAH)和出院时持续性低钠血症(PH)的患病率。我们还使用多变量逻辑回归和Cox比例风险模型,以正常血钠水平作为对照,研究了低钠血症对30天再入院率、住院期间和30天死亡率以及住院LOS和费用的影响。总体低钠血症的患病率为32.5%[95%置信区间(CI),31.3 - 33.6%],而在AH和HAH的住院病例中PH的患病率为33.7%(31.7 - 35.8%)。经过多变量调整后,低钠血症与住院费用增加相关(19,025 ± 485瑞士法郎 vs. 14,962 ± 341瑞士法郎,<0.001)以及LOS延长(13.4 ± 0.2天 vs. 10.7 ± 0.2天,<0.001)。低钠血症严重程度增加与更高的住院费用和LOS相关(趋势P<0.001)。低钠血症与更频繁的30天再入院存在趋势关联[调整后的比值比(OR),1.15(1.01 - 1.31),P = 0.032],主要与PH相关:调整后的OR = 1.41(1.17 - 1.71),<0.001。未发现低钠血症严重程度与再入院之间存在关联。低钠血症与住院期间[调整后的OR = 1.94(1.49 - 2.53),<0.001]和30天死亡率增加相关:调整后的OR = 1.80(1.44 - 2.24),<0.001。低钠血症严重程度增加与更高的住院期间和30天死亡率相关(趋势P<0.001)。低钠血症在住院患者中非常普遍,并且与LOS延长、早期医院再入院、住院期间和30天死亡率以及住院费用增加相关。PH与早期医院再入院和30天死亡率风险的大幅增加相关。